Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Diseases of the Thyroid

Free Subscription Articles published in Anticancer Res Retrieve available abstracts of 13 articles: HTML format

Single Articles

October 2025
1. HONG J, Fan R, Gao Y, Moes G, et al
   Sellar Metastatic Follicular Thyroid Carcinoma With Novel Mutations Clinically Mimicking Pituitary Macroadenoma: Intraoperative Frozen Section Diagnosis Challenges.
   Anticancer Res. 2025;45:4637-4641.
   PubMed     Abstract available
   
   
   September 2025
2. ANZELLINI D, Loddo M, Del Bianco S
   Long-lasting Complete Remission Following Immunotherapy With Anti-PD1 Plus Anti-CTLA4 in a Polymetastatic Patient With NRAS (Q16R) Mutated Anaplastic Thyroid Carcinoma.
   Anticancer Res. 2025;45:3809-3816.
   PubMed     Abstract available
   
   
   April 2025
3. HAYASHI K, Ishida K, Kato M, Ohkubo S, et al
   Activation of DCTN1-RET Fusion Through Coiled-coil Domain as a Potential Target for RET Inhibitors.
   Anticancer Res. 2025;45:1407-1417.
   PubMed     Abstract available
   
   
   December 2024
4. BOWERS JC, Savaliya BP, Raikot SR, Ahmed SH, et al
   Survival Outcomes and Disparities in Surgery Refusal for Papillary Thyroid Cancer.
   Anticancer Res. 2024;44:5455-5461.
   PubMed     Abstract available
   
   
   October 2024
5. MIYAKE R, Takeyama H, Manome Y, Koyama M, et al
   Thyroid Cancer With Autocrine Sialyl-fibronectin Depletion Has a Poor Prognosis due to EMT Progression.
   Anticancer Res. 2024;44:4561-4568.
   PubMed     Abstract available
   
   
   
6. NA YM, Park SC, An SY, Ma HU, et al
   Analysis of Initial Outcomes of Gas-insufflation One-step Single-port Transaxillary (GOSTA) Robotic Thyroidectomy for Thyroid Cancer.
   Anticancer Res. 2024;44:4585-4592.
   PubMed     Abstract available
   
   
   July 2024
7. TODA S, Saito N, Kadoya M, Okubo Y, et al
   Association of BRAF or TERT Promoter Mutations and Advanced Papillary Thyroid Carcinoma.
   Anticancer Res. 2024;44:3141-3147.
   PubMed     Abstract available
   
   
   May 2024
8. JI N, Lee Y, Lee SH, Kim HS, et al
   Diagnostic Value of Immunostaining for Thyroid Transcription Factor 1 (TTF1) and Paired Box 8 (PAX8) in Distinguishing Pulmonary Metastases of Mesonephric and Mesonephric-like Adenocarcinomas from Primary Lung Adenocarcinomas.
   Anticancer Res. 2024;44:2159-2170.
   PubMed     Abstract available
   
   
   January 2024
9. YOSHIMURA N, Fujiwara M, Igeta M, Suzuki H, et al
   Risk Factors Causing Hypothyroidism in Patients With Head and Neck Cancer After Radiotherapy Using SIB-VMAT.
   Anticancer Res. 2024;44:323-329.
   PubMed     Abstract available
   
   
   November 2023
10. KOWKABANY G, Jimenez PB, Sharan S, Bansal S, et al
    Inequities in Time to Treat Thyroid Cancer.
    Anticancer Res. 2023;43:5025-5030.
    PubMed     Abstract available
    
    
    October 2023
11. ZHOU J, Liu J, Zhang KE, Lv J, et al
    High-throughput Sequencing Analysis of Differentially Expressed microRNAs Associated With SREBP1 in Differentiated Thyroid Carcinoma.
    Anticancer Res. 2023;43:4435-4446.
    PubMed     Abstract available
    
    
    April 2023
12. LANDSTROM F, Sandberg J, Reizenstein J
    Life-threatening Airway Complication After Radioactive Iodine Treatment: A Case Report and Review of the Literature.
    Anticancer Res. 2023;43:1853-1855.
    PubMed     Abstract available
    
    
    March 2023
13. NAKAYAMA H, Saito N, Kasajima R, Suganuma N, et al
    Validation of EZH2 Inhibitor Efficiency in Anaplastic Thyroid Carcinoma Cell Lines.
    Anticancer Res. 2023;43:1073-1077.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Diseases of the Thyroid is free of charge.